Global Bulk Drug Raw Materials Procurement Market Intelligence Report 2017 Featuring Merck, Teva, Pfizer, AstraZeneca & BASF – iCrowdNewswire
 
x

RSS Newsfeeds

See all RSS Newsfeeds

Dec 7, 2017 2:45 PM ET

Global Bulk Drug Raw Materials Procurement Market Intelligence Report 2017 Featuring Merck, Teva, Pfizer, AstraZeneca & BASF

iCrowdNewswire - Dec 7, 2017

The “Global Bulk Drug Raw Materials – Procurement Market Intelligence Report” report has been added to Research and Markets’ offering.

Global Bulk Drug Raw Materials Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.

The increasing investments by suppliers in R&D add to the technological advancements in this market. Suppliers inculcate advanced technologies such as automation in lyophilization, modular continuous flow processing system, adoption of sensors for process control, and semi-automatic powder handling technology in the entire process of raw material manufacturing. Improvements in technologies help to enhance their productivity and quality of raw materials produced. The techniques mentioned above aid suppliers to achieve consistent cost savings through factors such as low-impurity rate and automation of the entire process.

Key Topics Covered:

PART 1: CATEGORY AT A GLANCE

PART 2: SCOPE OF THE REPORT

– Category Definition
– Research Methodology

PART 3: MARKET INSIGHTS

– Category Spend Analysis
– Category Maturity by Regions
– Demand-Supply Shifts
– Regional Demand-Supply Snapshot
– Global Molasses Production Hubs
– Market Developments
– Regional Impact of Trends
– Key Category Growth Drivers and Corresponding Regional Impacts
– Major Category Growth Constraints and Corresponding Regional Impacts
– Key Current Technological Innovations
– Major Regulatory Frameworks
– Strategic Sustainability Practices
– Porter’s Five Forces
– PESTLE Analysis

PART 4: SUPPLY MARKET INSIGHTS

– Supplier Operational Capability Matrix
– Other Prominent Suppliers by Region: Operational Capability Matrix
– Supplier Functional Capability Matrix
– Other Prominent Suppliers by Region: Functional Capability Matrix
– Key Clients/Partners
– Supplier Cost Breakup
– Supplier Positioning Matrix

PART 5: PRICING INSIGHTS

– Pricing Models Snapshot
– Pricing Models – Pros and Cons
– Indicative Pricing

PART 6: PROCUREMENT INSIGHTS

– Major Category Requirements
– Major Procurement Pain Points
– Category Sourcing Evolution Matrix
– Procurement Best Practices
– Cost-saving Opportunities
– Supplier Selection Criteria
– Category Negotiation Strategies
– SLA Terms
– Supplier Evaluation Criteria
– Category Risk Analysis

PART 7: TOP FIVE SUPPLIERS

– Merck
– Teva
– Pfizer
– AstraZeneca
– BASF

For more information about this report visit https://www.researchandmarkets.com/research/3r54st/global_bulk_drug?w=3

Contact Information:

Research and Markets,
Laura Wood,
Senior Manager.
[email protected]
Related Topics: Pharmaceuticals (https://www.researchandmarkets.com/categories.asp?cat_id=16&campaign_id=3r54st)

Via iCrowdNewswire
View Related News >